AK
ALK-Abelló A/S
AKBLF · OTC
$32.47 +0.00% (+$0.00)
Market Cap 42.6B kr
P/E Ratio 31.46x
Div. Yield 0.77%
ROE 20.76%
Bulios Fair Price
$25.44
21.7% downside
Trenutna cena
$32.47
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica AKBLF trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
8/9Valuation
42 /100
Fair P/FCF 22.64x
P/E 31.46x
P/B 6.16x
Growth
91 /100
Growing FCF growth 190.06%
EPS growth 53.02%
Book val. growth 17.26%
Profitability
100 /100
Strong Op. margin 26.72%
Gross margin 68.04%
FCF margin 27.60%
Quality
86 /100
Excellent ROA 13.98%
ROIC 16.14%
Asset turnover 0.70x
Debt
100 /100
Low Net debt/EBITDA -0.60x
Debt/Equity 0.06x
Current ratio 3.46x
Stability
100 /100
Stable EPS volatility 12.10%
Beta 0.71x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o AKBLF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Halling
Employees
2,721
Headquarters
Horsholm
Prihajajoči dogodki
17 NOV.
Earnings
Upcoming earnings report